How to cope with COVID-19 quarantine fatigue
How can you counteract your COVID-19 quarantine fatigue? Here are seven tips from our licensed clinical psychologist Catherine Powers-James, Ph.D.
Related Articles
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer | Exelixis, Inc.
The Investor Relations website contains information about Exelixis, Inc.’s business for stockholders, potential investors, and financial analysts.
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | NEJM
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | NEJM
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | NEJM
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma
PURPOSEAcral lentiginous melanoma is a subtype of cutaneous melanoma arising from palmar, plantar, or subungual skin. These tumors are characterized by aggressive biology, a low…
Clinical Implications of a Large-Scale Voluntary Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine: Preliminary Results | JCO Oncology Practice
PURPOSETo assess the impact and outcomes of a novel program for routine preemptive DPYD testing in fluoropyrimidine (FP)-naïve patients.PATIENTS AND METHODSThis single-center, retrospective cohort study…
Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice
In the current evolving landscape of cancer treatment, the notion that all patients with advanced cancer, but especially those with rare cancers, must receive comprehensive…
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis
Universal germline and tumor genomic testing needed to win the war against cancer.
Universal Genomic Testing Needed to Win the War Against Cancer
This Viewpoint argues for universal tumor sequencing.
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras
The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the…